Please assess the completion status of the following clinical trial:

Trial Title: Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Women aged 18-45 years with a diagnosis of BV according to Amsel's criteria and a Nugent score of ≥4~* Otherwise healthy~Exclusion Criteria:~* No active STIs

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 0.5% SPL7013 Gel (Type: EXPERIMENTAL): None
- 1.0% SPL7013 Gel (Type: EXPERIMENTAL): None
- 3.0% SPL7013 Gel (Type: EXPERIMENTAL): None
- Placebo Gel (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).